Incidence and risk of antiresorptive agent-related osteonecrosis of the jaw (ARONJ) after tooth extraction in patients with autoimmune disease.

Yuichiro FujiedaMototsugu DoiTakuya AsakaMasahiro OtaRyo HisadaNaoki OhnishiMichihiro KonoHiraku KamedaDaigo NakazawaMasaru KatoOlga AmengualMasahiko TakahataShinsuke YasudaYoshimasa KitagawaTatsuya Atsumi

Published in: Journal of bone and mineral metabolism (2020)

Patients with AID who undergo dental extraction are at high risk of ARONJ. Discontinuation of AR would not significantly contribute to reduce the incidence of ARONJ in those patients.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
multiple sclerosis
prognostic factors